ClinConnect ClinConnect Logo
Search / Trial NCT04730830

Occurrence of Emerging Infections After Placement of a Peritoneal Dialysis CatHeter

Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE BESANCON · Jan 26, 2021

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Renal Disease Peritoneal Dialysis Emergence Infections

ClinConnect Summary

This clinical trial is studying the occurrence of infections at the site where a catheter is placed for peritoneal dialysis, a treatment for patients with end-stage kidney disease. The goal is to better understand how often these infections happen and to evaluate a scoring system that might help identify them more clearly. Researchers want to gather more data to improve infection prevention strategies and ensure better care for patients using peritoneal dialysis.

To participate in this study, individuals must be between 18 and 80 years old and have end-stage renal disease, meaning their kidneys are no longer functioning properly and they are starting treatment with peritoneal dialysis. Participants will need to sign an informed consent form and be covered by French social security. Those who are pregnant, unable to cooperate with the study, or have certain legal or health issues may not be eligible. If you join this trial, you can expect to help researchers learn more about managing and preventing infections, which could lead to better treatment options in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Men and women aged 18 to 80 inclusive
  • Signature of informed consent
  • Affiliation to a French social security scheme
  • Patient with end stage renal disease starting renal replacement therapy by peritoneal dialysis in one of the participating centers
  • Exclusion Criteria:
  • Legal incapacity or limited legal capacity
  • Subject unlikely to cooperate with the study and / or weak cooperation anticipated by the investigator
  • Pregnant woman
  • Subject being in the period of exclusion from another study or provided for by the "national file of volunteers".
  • Patient without health insurance
  • Inability to understand the reasons for the study; psychiatric disorder judged by the investigator to be incompatible with inclusion in the study.

About Centre Hospitalier Universitaire De Besancon

The Centre Hospitalier Universitaire de Besançon (CHU de Besançon) is a leading academic medical center located in Besançon, France, dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, CHU de Besançon focuses on a wide range of medical disciplines, fostering collaboration between healthcare professionals and researchers to develop new therapeutic strategies and improve patient outcomes. With a commitment to rigorous scientific standards and ethical practices, the institution plays a vital role in translating research findings into practical applications, ultimately enhancing the quality of care provided to the community.

Locations

Besançon, , France

Besançon, , France

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials